| Size | 100 µg, 500 µg, 1000 µg |
| Estimated Lead Time | 1-2 business days |
| Species | SARS-CoV-2 |
| Accession Number | QHD43416 |
| Protein Name / Synonyms | Spike protein, S Protein, S1 Subunit, Host Cell Receptor Binding Domain (RBD) |
| Expressed Region | Arg319-Phe541 |
| Expression System | HEK293 cells |
| Tag | C-terminal his-tag |
| Purity | >95 % |
| Purity Determined By | SDS-PAGE under reducing conditions and visualized by Coomassie blue staining |
| Molecular Weight (kDa) | Recombinant protein product has a calculated molecular mass of 25 kDa. Due to the abundant glycosylation, it migrates as approximately 30 kDa protein bands in SDS-PAGE under DTT, beta-mercaptoethanol reducing conditions. See deglycosylation analysis image below. |
| Format | Liquid |
| Formulation | Supplied as a 0.2 µm filtered solution in PBS (pH 7.4) |
| Concentration (lot specific) | Lot specific (see the label on the vial), determined by BCA protein assay |
| Research Area | Antibody Drug Development, Receptor-Ligand Binding, Infectious Disease, COVID-19 |
| Shipping Type | Blue ice |
| Storage | -20°C |
SARS-CoV-2, the virus responsible for COVID-19, uses its spike protein to enter host cells, with the receptor-binding domain (RBD) playing a central role in this process. The RBD within the S1 subunit specifically binds to the angiotensin-converting enzyme 2 (ACE2) receptor on human cells, facilitating viral entry and subsequent infection. This domain is a key target for neutralizing antibodies and vaccine design.
Reference: https://link.springer.com/chapter/10.1007/978-3-031-46545-1_13
Recombinant SARS-CoV-2, S1 Subunit Protein (RBD)
Recombinant SARS-CoV-2, S1 Subunit Protein (RBD)
We emploied this protein for site-specific glycosylation analysis. It works great.
Review by Anonymous, from University of California, Davis, on Mar 16, 2021